Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortNNRTI used in first-line HIV regimens, with vivid dreams as a common side effect.Backbone drug for HIV treatment, PrEP and hepatitis B.
Body systemAntiviralsAntivirals
Drug classNon-nucleoside reverse transcriptase inhibitorsNucleos(t)ide reverse transcriptase inhibitors
SupplyPrescription onlyWHO essential medicinePrescription onlyWHO essential medicine
Main usesHIV infection (with other drugs)HIV treatment, HIV pre-exposure prophylaxis (PrEP, with emtricitabine), Chronic hepatitis B
How it worksBlocks HIV from copying itself.A fake DNA building block that stops HIV and hepatitis B copying themselves.
Starts workingWeeks—
Half-life40–55 hoursAbout 17 hours in plasma
Typical adult dose600 mg once a day at bedtime.300 mg (245 mg tenofovir disoproxil) once a day.
FormsTablet, Combination tabletsTablet, Combination tablets
Common side effectsVivid dreams, Dizziness, Rash, Insomnia, Difficulty concentratingNausea, Diarrhoea, Headache, Dizziness
Serious side effectsDepression and suicidal thoughts, Liver injury, Severe skin reactions, QT prolongationKidney damage, Bone thinning, Hepatitis B flare if stopped suddenly
Don't take ifSevere liver disease; Depression with suicidal thoughts; First trimester without alternatives—
AlcoholBest avoided. Alcohol adds to dizziness and liver stress.—
PregnancyUse with cautionConsidered safe after the first trimester; contraception is advised.Generally considered safeWidely used in pregnancy for HIV and hepatitis B.
BreastfeedingUsually avoidedNot recommended where safe formula is available.—
In use since—2001
Brand namesUnited States: Sustiva, Atripla (combination)United Kingdom: SustivaIndia: Efavir, ViranzUnited States: Viread, Truvada (with emtricitabine)United Kingdom: Viread, TruvadaIndia: Tenvir
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H—
ATC codeJ05AG03J05AF07

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker